In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin

MLA

E. Alvirez-Freites, et al. “In Vitro Susceptibility of Nocardia Species to Cethromycin, Clarithromycin and Amikacin.” European Journal of Clinical Microbiologyinfectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 23, no. 1, Dec. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f153fe96f35e309ebb7244925eb3ac5b&authtype=sso&custid=ns315887.

APA

E. Alvirez-Freites, Michael H. Cynamon, M. S. DeStefano, & Anthony E. T. Yeo. (2003). In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin. European Journal of Clinical Microbiologyinfectious Diseases : Official Publication of the European Society of Clinical Microbiology, 23(1).

Chicago

E. Alvirez-Freites, Michael H. Cynamon, M. S. DeStefano, and Anthony E. T. Yeo. 2003. “In Vitro Susceptibility of Nocardia Species to Cethromycin, Clarithromycin and Amikacin.” European Journal of Clinical Microbiologyinfectious Diseases : Official Publication of the European Society of Clinical Microbiology 23 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f153fe96f35e309ebb7244925eb3ac5b&authtype=sso&custid=ns315887.